-
1
-
-
84877103716
-
Vaccines, reverse vaccinology, and bacterial pathogenesis
-
Delany I, Rappuoli R, Seib KL. Vaccines, reverse vaccinology, and bacterial pathogenesis. Cold Spring Harb Perspect Med 2013;3:a012476.
-
(2013)
Cold Spring Harb Perspect Med
, vol.3
, pp. a012476
-
-
Delany, I.1
Rappuoli, R.2
Seib, K.L.3
-
2
-
-
77958454595
-
Reverse vaccinology: developing vaccines in the era of genomics
-
Sette A, Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 2010;33:530-41.
-
(2010)
Immunity
, vol.33
, pp. 530-541
-
-
Sette, A.1
Rappuoli, R.2
-
4
-
-
84899493964
-
Identification of potential vaccine candidates against Streptococcus pneumoniae by reverse vaccinology approach
-
Talukdar S, Zutshi S, Prashanth KS et al. Identification of potential vaccine candidates against Streptococcus pneumoniae by reverse vaccinology approach. Appl Biochem Biotechnol 2014;172:3026-41.
-
(2014)
Appl Biochem Biotechnol
, vol.172
, pp. 3026-3041
-
-
Talukdar, S.1
Zutshi, S.2
Prashanth, K.S.3
-
5
-
-
80053647416
-
Improving reverse vaccinology with a machine learning approach
-
Bowman BN, McAdam PR, Vivona S et al. Improving reverse vaccinology with a machine learning approach. Vaccine 2011;29:8156-64.
-
(2011)
Vaccine
, vol.29
, pp. 8156-8164
-
-
Bowman, B.N.1
McAdam, P.R.2
Vivona, S.3
-
6
-
-
84879494011
-
Jenner-predict server:prediction of protein vaccine candidates (PVCs) in bacteria based on host-pathogen interactions
-
Jaiswal V, Chanumolu SK, Gupta A et al. Jenner-predict server:prediction of protein vaccine candidates (PVCs) in bacteria based on host-pathogen interactions. BMC Bioinformatics 2013;14:211.
-
(2013)
BMC Bioinformatics
, vol.14
, pp. 211
-
-
Jaiswal, V.1
Chanumolu, S.K.2
Gupta, A.3
-
8
-
-
84900385250
-
Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention
-
Esposito S, Castellazzi L, Bosco A et al. Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention. Immunotherapy 2014;6:395-408.
-
(2014)
Immunotherapy
, vol.6
, pp. 395-408
-
-
Esposito, S.1
Castellazzi, L.2
Bosco, A.3
-
9
-
-
77955360252
-
Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development
-
2010
-
He Y, Xiang Z, Mobley HL. Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J Biomed Biotechnol 2010;2010:297505.
-
(2010)
J Biomed Biotechnol
, pp. 297505
-
-
He, Y.1
Xiang, Z.2
Mobley, H.L.3
-
10
-
-
84924466660
-
-
Atlanta: U.S. Department of Health and Human Services, Centers for Disease, Control and Prevention;
-
U.S. Department of Health and Human Services CfD, Control and Prevention. Antibiotic resistance threats in the United States, 2013. Atlanta: U.S. Department of Health and Human Services, Centers for Disease, Control and Prevention; 2013.
-
(2013)
-
-
-
11
-
-
33750223990
-
Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham
-
UK, 12-13 December 2005
-
Finch R, Hunter PA. Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005. J Antimicrob Chemother 2006;58(Suppl 1):i3-22.
-
(2006)
J Antimicrob Chemother
, vol.58
, pp. i3-22
-
-
Finch, R.1
Hunter, P.A.2
-
13
-
-
33746456834
-
CED: a conformational epitope database
-
Huang J, Honda W. CED: a conformational epitope database. BMC Immunol 2006;7:7.
-
(2006)
BMC Immunol
, vol.7
, pp. 7
-
-
Huang, J.1
Honda, W.2
-
14
-
-
77958498224
-
Vaccine adjuvants: putting innate immunity to work
-
Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity 2010;33:492-503.
-
(2010)
Immunity
, vol.33
, pp. 492-503
-
-
Coffman, R.L.1
Sher, A.2
Seder, R.A.3
-
15
-
-
77955421572
-
Hepatitis B vaccines: protective efficacy and therapeutic potential
-
Michel ML, Tiollais P. Hepatitis B vaccines: protective efficacy and therapeutic potential. Pathol Biol (Paris) 2010;58:288-95.
-
(2010)
Pathol Biol (Paris)
, vol.58
, pp. 288-295
-
-
Michel, M.L.1
Tiollais, P.2
-
16
-
-
23244467904
-
Boostrix (GlaxoSmithKline)
-
Jones T. Boostrix (GlaxoSmithKline). IDrugs 2005;8:656-61.
-
(2005)
IDrugs
, vol.8
, pp. 656-661
-
-
Jones, T.1
-
17
-
-
84873378947
-
Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine, adsorbed (boostrix (R)): a guide to its use as a single-dose booster immunization against pertussis
-
Scott LJ, McCormack PL. Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine, adsorbed (boostrix (R)): a guide to its use as a single-dose booster immunization against pertussis. BioDrugs 2013;27:75-81.
-
(2013)
BioDrugs
, vol.27
, pp. 75-81
-
-
Scott, L.J.1
McCormack, P.L.2
-
18
-
-
84924466659
-
Novartis Bexsero® meningitis B vaccine receives clinical recommendation for use in infants and adolescents in Australia
-
17 March, accessed 10 September 2014
-
Friend R, Staton T. Novartis Bexsero® meningitis B vaccine receives clinical recommendation for use in infants and adolescents in Australia. FierceVaccines, 17 March 2014. http://www.fiercepharma. com/press-releases/novartis-bexsero-meningitis-b-vaccine-receivesclinical- recommendation-use [accessed 10 September 2014].
-
(2014)
FierceVaccines
-
-
Friend, R.1
Staton, T.2
-
19
-
-
0034629284
-
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
-
Pizza M, Scarlato V, Masignani V et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000;287:1816-20.
-
(2000)
Science
, vol.287
, pp. 1816-1820
-
-
Pizza, M.1
Scarlato, V.2
Masignani, V.3
-
21
-
-
79958035895
-
Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles
-
Bai X, Findlow J, Borrow R. Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles. Expert Opin Biol Ther 2011;11:969-85.
-
(2011)
Expert Opin Biol Ther
, vol.11
, pp. 969-985
-
-
Bai, X.1
Findlow, J.2
Borrow, R.3
-
22
-
-
84893929367
-
Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero(R) vaccine
-
Tani C, Stella M, Donnarumma D et al. Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero(R) vaccine. Vaccine 2014;32:1273-9.
-
(2014)
Vaccine
, vol.32
, pp. 1273-1279
-
-
Tani, C.1
Stella, M.2
Donnarumma, D.3
-
23
-
-
84924466658
-
-
Meningitis B Vaccine, accessed 10 May 2014
-
NHS. Meningitis B Vaccine. http://www.nhs.uk/Conditions/vaccinations/ Pages/meningitis-B-vaccine.aspx [accessed 10 May 2014].
-
-
-
-
24
-
-
84898007270
-
vaccine to be introduced in UK after U turn on its cost effectiveness
-
Wise J. Meningitis B vaccine to be introduced in UK after U turn on its cost effectiveness. BMJ 2014;348:2327.
-
(2014)
BMJ
, vol.348
, pp. 2327
-
-
Wise, J.1
Meningitis, B.2
-
25
-
-
19944423389
-
Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings
-
Finco O, Bonci A, Agnusdei M et al. Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings. Vaccine 2005;23:1178-88.
-
(2005)
Vaccine
, vol.23
, pp. 1178-1188
-
-
Finco, O.1
Bonci, A.2
Agnusdei, M.3
-
26
-
-
14844324488
-
Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis
-
Gamberini M, Gomez RM, AtzingenMVet al. Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis. FEMS Microbiol Lett 2005;244:305-13.
-
(2005)
FEMS Microbiol Lett
, vol.244
, pp. 305-313
-
-
Gamberini, M.1
Gomez, R.M.2
Atzingen, M.V.3
-
27
-
-
0036893688
-
Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening
-
Ariel N, Zvi A, Grosfeld H et al. Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening. Infect Immun 2002;70:6817-27.
-
(2002)
Infect Immun
, vol.70
, pp. 6817-6827
-
-
Ariel, N.1
Zvi, A.2
Grosfeld, H.3
-
28
-
-
33745617720
-
Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen
-
Gat O, Grosfeld H, Ariel N et al. Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen. Infect Immun 2006;74:3987-4001.
-
(2006)
Infect Immun
, vol.74
, pp. 3987-4001
-
-
Gat, O.1
Grosfeld, H.2
Ariel, N.3
-
29
-
-
0035114563
-
Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection
-
Wizemann TM, Heinrichs JH, Adamou JE et al. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun 2001;69:1593-8.
-
(2001)
Infect Immun
, vol.69
, pp. 1593-1598
-
-
Wizemann, T.M.1
Heinrichs, J.H.2
Adamou, J.E.3
-
30
-
-
1642498273
-
Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins
-
Lei B, Liu M, Chesney GL, Musser JM. Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins. J Infect Dis 2004;189:79-89.
-
(2004)
J Infect Dis
, vol.189
, pp. 79-89
-
-
Lei, B.1
Liu, M.2
Chesney, G.L.3
Musser, J.M.4
-
31
-
-
7044274377
-
Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening
-
Bhatia V, Sinha M, Luxon B, Garg N. Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening. Infect Immun 2004;72:6245-54.
-
(2004)
Infect Immun
, vol.72
, pp. 6245-6254
-
-
Bhatia, V.1
Sinha, M.2
Luxon, B.3
Garg, N.4
-
32
-
-
33847031827
-
VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines
-
Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics 2007;8:4.
-
(2007)
BMC Bioinformatics
, vol.8
, pp. 4
-
-
Doytchinova, I.A.1
Flower, D.R.2
-
33
-
-
84904732727
-
Vacceed: a high-throughput in silico vaccine candidate discovery pipeline for eukaryotic pathogens based on reverse vaccinology
-
Goodswen SJ, Kennedy PJ, Ellis JT. Vacceed: a high-throughput in silico vaccine candidate discovery pipeline for eukaryotic pathogens based on reverse vaccinology. Bioinformatics 2014;30:2381-3.
-
(2014)
Bioinformatics
, vol.30
, pp. 2381-2383
-
-
Goodswen, S.J.1
Kennedy, P.J.2
Ellis, J.T.3
-
34
-
-
84886737285
-
A novel strategy for classifying the output from an in silico vaccine discovery pipeline for eukaryotic pathogens using machine learning algorithms
-
Goodswen SJ, Kennedy PJ, Ellis JT. A novel strategy for classifying the output from an in silico vaccine discovery pipeline for eukaryotic pathogens using machine learning algorithms. BMC Bioinformatics 2013;14:315.
-
(2013)
BMC Bioinformatics
, vol.14
, pp. 315
-
-
Goodswen, S.J.1
Kennedy, P.J.2
Ellis, J.T.3
-
35
-
-
33747839161
-
SVMHC: a server for prediction of MHC-binding peptides
-
Web Server issue
-
Donnes P, Kohlbacher O. SVMHC: a server for prediction of MHC-binding peptides. Nucleic Acids Res 2006;34(Web Server issue):W194-7.
-
(2006)
Nucleic Acids Res
, vol.34
, pp. W194-W197
-
-
Donnes, P.1
Kohlbacher, O.2
-
37
-
-
80055113866
-
Legionella: Drinking water fact sheet
-
Washington DC: United States Environmental Protection Agency Office of Wate;
-
United States Environmental Protection Agency. Legionella: Drinking water fact sheet. Washington DC: United States Environmental Protection Agency Office of Wate; 2000.
-
(2000)
-
-
-
38
-
-
84867609003
-
Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila [in Chinese]
-
Yu LL, Hu BJ, Huang SL et al. Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila [in Chinese]. Zhonghua Jie He He Hu Xi Za Zhi 2011;34:409-12.
-
(2011)
Zhonghua Jie He He Hu Xi Za Zhi
, vol.34
, pp. 409-412
-
-
Yu, L.L.1
Hu, B.J.2
Huang, S.L.3
-
39
-
-
84897934240
-
Bacterial outer membrane vesicles and vaccine applications
-
Acevedo R, Fernandez S, Zayas C et al. Bacterial outer membrane vesicles and vaccine applications. Front Immunol 2014;5:121.
-
(2014)
Front Immunol
, vol.5
, pp. 121
-
-
Acevedo, R.1
Fernandez, S.2
Zayas, C.3
|